Viewing Study NCT00306592


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-03-05 @ 1:15 PM
Study NCT ID: NCT00306592
Status: COMPLETED
Last Update Posted: 2017-03-21
First Post: 2006-01-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Natalizumab Re-Initiation of Dosing
Sponsor:
Organization: